Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026

Bulletin Express

May 26

Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.

The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.

The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1176084051"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176084051\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176084051?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176084051","market":"us","top_or_hot":-1,"title":"Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026","media":"Bulletin Express","content":"<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.</p>\n<p>The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.</p>\n<p>The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.</p>\n<p>The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.</p>\n<p>The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1176084051","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176084051","pubTimestamp":1779786212,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"英矽智能加入恒生生物科技指数，自2026年6月8日起生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.\nThe Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.\nThe Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}